Some results of the clinical trial in the treatment of the benign prostatic hypertrophy by blastolysin - hepaton - promolan
- Author:
Ket Van Duong
- Publication Type:Journal Article
- Keywords:
benign prostatic hyperplasia
- MeSH:
Prostatic Hyperplasia;
therapy
- From:Journal of Vietnamese Medicine
1999;232(1):63-66
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Blastolysin - hepaton - promolan is a traditional remedy to treat and prevent chorioepithelioma especially in mild and moderate cases. This remedy has been proved to apply in benign prostatic hyperplasia. Evaluation after treatment by taking drug continuously in three months: Obstacle and irritable symptoms reduce in almost patients. Volume of prostate in echography image became significantly smaller. Initial results: very good 9 cases (19.1%), good 19 cases (40.4%), moderate is 16 cases (34.0%), poor 3 cases (6.3%). This remedy is not poisonous is widely indicated and suitable for many kind of patients such as elder patients, suffering from many diseases, no indication or unwillingness for operation... It costs less than ongoing therapy. As being hypertrophy prostate is current subject, many doctors and even patients concerned with, blastolysin therapy should be studied further.
